Allergic conjunctivitis secondary prevention: Difference between revisions
| Line 5: | Line 5: | ||
===Early diagnosis=== | ===Early diagnosis=== | ||
The [[diagnosis]] should be confirmed and the severity assessed by a proper history and a thorough physical examination. | The [[diagnosis]] should be confirmed and the severity assessed by a proper history and a thorough physical examination. | ||
===[[Treatment]]=== | |||
The dual-activity agents are considered the appropriate first-line therapy. They are easily accessible and well tolerated. When symptoms and signs remain uncontrolled, a short course of topical ophthalmic steroids may be considered. As discussed above, monitoring by an eye care specialist is necessary when there is consideration to use this agent on a longer term basis. Other treatments include nasal steroids, oral anti-histamines and/or topical ophthalmic NSAIDs, which are listed in no particular order and can be used concomitantly. Topical calcineurin inhibitors can be used off-label by eyecare specialists as a next step. Immunotherapy, either subcutaneous or sublingual, can provide a longer term solution to the symptoms and signs of AC and can be considered when medical therapy is insufficient, poorly tolerated or for patient preference. | |||
==References== | ==References== | ||
Revision as of 04:14, 30 August 2022
|
Allergic conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Allergic conjunctivitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Allergic conjunctivitis secondary prevention |
|
Risk calculators and risk factors for Allergic conjunctivitis secondary prevention |
Overview
Secondary Prevention
Early diagnosis
The diagnosis should be confirmed and the severity assessed by a proper history and a thorough physical examination.
Treatment
The dual-activity agents are considered the appropriate first-line therapy. They are easily accessible and well tolerated. When symptoms and signs remain uncontrolled, a short course of topical ophthalmic steroids may be considered. As discussed above, monitoring by an eye care specialist is necessary when there is consideration to use this agent on a longer term basis. Other treatments include nasal steroids, oral anti-histamines and/or topical ophthalmic NSAIDs, which are listed in no particular order and can be used concomitantly. Topical calcineurin inhibitors can be used off-label by eyecare specialists as a next step. Immunotherapy, either subcutaneous or sublingual, can provide a longer term solution to the symptoms and signs of AC and can be considered when medical therapy is insufficient, poorly tolerated or for patient preference.